Literature DB >> 2376167

Exercise limitation in patients with polymyositis.

C A Hebert1, T J Byrnes, B A Baethge, R E Wolf, G T Kinasewitz.   

Abstract

To examine the hypothesis that patients with inflammatory muscle disease have impairments in cardiac and/or pulmonary function that are masked by peripheral muscle weakness, complete PFTs, echo/Doppler studies and exercise testing were performed in 11 patients with polymyositis. Maximal inspiratory and expiratory pressures and expiratory flow rates were normal. One patient had evidence of restrictive lung disease; two had a reduced Dsb. Seven patients had evidence of pulmonary hypertension. Only three patients had normal aerobic capacity; VO2 max in the other 8 patients was 46 +/- 8 percent of predicted when they stopped exercising. Four patients had a normal O2 pulse; seven patients had a reduced O2 pulse while five of seven patients exceeded 85 percent of their target heart rate. We conclude that while asymptomatic impairments in pulmonary function are uncommon in polymyositis, the incidence of pulmonary hypertension is high, but symptoms may be masked by the peripheral muscle weakness.

Entities:  

Mesh:

Year:  1990        PMID: 2376167     DOI: 10.1378/chest.98.2.352

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  The benefits and limitations of a physical training program in patients with inflammatory myositis.

Authors:  M Lawson Mahowald
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  Pulmonary hypertension in polymyositis.

Authors:  Han Wang; Tao Liu; Ying-ying Cai; Lian Luo; Meng Wang; Mengmeng Yang; Lin Cai
Journal:  Clin Rheumatol       Date:  2015-10-14       Impact factor: 2.980

Review 3.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  Armin Schnabel; Bernhard Hellmich; Wolfgang Ludwig Gross
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 4.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

Review 5.  Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.

Authors:  Sébastien Sanges; Cécile M Yelnik; Olivier Sitbon; Olivier Benveniste; Kuberaka Mariampillai; Mathilde Phillips-Houlbracq; Christophe Pison; Christophe Deligny; Jocelyn Inamo; Vincent Cottin; Luc Mouthon; David Launay; Marc Lambert; Pierre-Yves Hatron; Laurence Rottat; Marc Humbert; Eric Hachulla
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.